Corticosterone synthesis inhibitor metyrapone ameliorates chronic hypobaric hypoxia induced memory impairment in rat

Behavioural Brain Research

Volumn 228, Issue 1, 2012, Pages 53-65

  Baitharu, Iswar ^a   Deep, Satya Narayan ^a   Jain, Vishal ^a   Barhwal, Kalpana ^b   Malhotra, Anand Swaroop ^a   Hota, Sunil Kumar ^b   Prasad, Dipti ^a   Ilavazhagan, Govindasamy ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

^b Leh Ladakh C o 56APO   (India)

Author keywords

Corticosterone; Glut1; Hippocampus; Hypobaric hypoxia; Memory impairment; Metyrapone; Neurodegeneration; Oxidative stress

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ADENOSINE TRIPHOSPHATE; CASPASE 3; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUTATHIONE; GLUTATHIONE DISULFIDE; METYRAPONE; MINERALOCORTICOID RECEPTOR; REACTIVE OXYGEN METABOLITE;

ALTITUDE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; CELL ENERGY; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORT; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MAZE TEST; MEMORY DISORDER; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECALL; RECEPTOR UPREGULATION;

EID: 83655169827     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.11.030     Document Type: Article

References (65)

1. Maiti P., Singh S.B., Muthuraju S., Veleri S., Ilavazhagan G. Hypobaric hypoxia damages the hippocampal pyramidal neurons in the rat brain. Brain Res 2007, 1175:1-9.
2. Hota S.K., Barhwal K., Singh S.B., Sairam M., Ilavazhagan G. NR1 and GluR2 expression mediates excitotoxicity in chronic hypobaric hypoxia. J Neurosci Res 2008, 86(5):1142-1152.
3. Barhwal K., Hota S.K., Baitharu I., Prasad D., Singh S.B., Ilavazhagan G. Isradipine antagonizes hypobaric hypoxia induced CA1 damage and memory impairment: complementary roles of L-type calcium channel and NMDA receptors. Neurobiol Dis 2009, 34(2):230-244.
4. Behl C., Lezoualch F., Trapp T., Widmann M., Skutella T., Holsboer F. Glucocorticoid enhances oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 1997, 138:101-106.
5. Moghaddam B., Boliano M., Stein-Behrens B., Sapolsky R.M. Glucocorticoids mediate stress-induced accumulation of extracellular glutamate. Brain Res 1994, 655:251-256.
6. Goodman Y., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 1996, 66:1836-1844.
7. Chameau P., Qin Y., Spijker S., Smith G., Joels M. Glucocorticoids specifically enhance L-type calcium current amplitude and affect calcium channel subunit expression in the mouse hippocampus. J Neurophysiol 2007, 97(1):5-14.
8. Olgemoller B., Schon J., Wieland O.H. Endothelial plasma membrane is a glucocorticoid regulated barrier for the uptake of glucose into the cell. Mol Cell Endocrinol 1985, 43:165-171.
9. Doyle P., Rohner-Jeanrenaud F., Jeanrenaud B. Local cerebral glucose utilization in brains of lean and genetically obese (fa/fa) rats. Am J Physiol 1993, 264:E29-E36.
10. Faraji J., Lehmann H., Metz G.A., Sutherland R.J. Stress and corticosterone enhance cognitive recovery from hippocampal stroke in rats. Neurosci Lett 2009, 462(3):248-252.
11. Veldhuis H.D., Van Coppen C., Van Ittersum M., De Kloet E.R. Specificity of the adrenal steroid receptor system in rat hippocampus. Endocrinology 1982, 110:2044-2051.
12. Reul J.M., De Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511.
13. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998, 19:269-301.
14. Seckl J.R., Walker B.R. 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001, 142(4):1371-1376.
15. Moisan M.P., Seckl J.R., Edwards C.R.W. 11β-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus and cortex. Endocrinology 1990, 127:1450-1455.
16. Rajan V., Edwards C.R.W., Seckl J.R. 11b-hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J Neurosci 1996, 16:65-70.
17. Yau J.L., Noble J., Kenyon C.J., Hibberd C., Kotelevtsev Y., Mullins J.J., et al. Lack of tissue glucocorticoid reactivation in 11β-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age related learning impairments. Proc Natl Acad Sci 2001, 98:4716-4721.
18. Bruehl H., Rueger M., Dziobek I., Sweat V., Tirsi A., Javier E., et al. Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J Clin Endocrinol Metab 2007, 92(7):2439-2445.
19. Akirav I., Kozenicky M., Tal D., Sandi C., Venero C., Richter-Levin G. A facilitative role for corticosterone in the acquisition of a spatial task under moderate stress. Learn Mem 2004, 11(2):188-195.
20. Smith-Swintosky V.L., Pettigrew L.C., Sapolsky R.M., Phares C., Craddock S.D., Brooke S.M., et al. Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J Cereb Blood Flow Metab 1996, 16(4):585-598.
21. Wong Y.N., Chien B.M., D'mello A.P. Analysis of corticosterone in rat plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl 1994, 661(2):211-218.
22. 2-induced oocyte maturation involves steroidogenesis in cat fish. J Endocrinol 2006, 189:341-353.
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
24. LeBel C.P., Ali S.F., McKee M., Bondy S.C. Organometal-induced increases in oxygen reactive species: the potential of 2',7'-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol Appl Pharmacol 1990, 104(1):17-24.
25. Myhre O., Andersen J.M., Aarnes H., Fonnum F. Evaluation of the probes 2',7'-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem Pharmacol 2003, 65(10):1575-1582.
26. Das N.P., Ratty A.K. Studies on the effects of the narcotic alkaloids, cocaine, morphine, and codeine on nonenzymatic lipid peroxidation in rat brain mitochondria. Biochem Med Metab Biol 1987, 37(2):258-264.
27. Colado M.I., O.Shea E., Granaburn litvakdos R., Murray T.K., Green A.R. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA and p-chloroamphetamine but not the degeneration following fenfluramine. Br J Pharmacol 1997, 121(5):889-900.
28. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976, 74(1):214-226.
29. Morris R.G.M. Development of a water maze procedure for studying spatial learning the rat. J Neurosci Methods 1984, 11:47-60.
30. Barhwal K., Singh S.B., Hota S.K., Jayalakshmi K., Ilavazhagan G. Acetyl-l-carnitine ameliorates hypobaric hypoxic impairment and spatial memory deficits in rats. Eur J Pharmacol 2007, 570(1-3):97-107.
31. Muthuraju S., Maiti P., Solanki P., Sharma A.K., Amitabh Singh S.B., Prasad D., et al. Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia. Behav Brain Res 2009, 203(1):1-14.
32. Netto C.A., Hodges H., Sinden J.D., Le Peillet E., Kershaw T., Sowinski P., et al. Effects of fetal hippocampal grafts on ischemic-induced deficits in spatial navigation in the water maze. Neuroscience 1993, 54:69-72.
33. Coburn-Litvak P.S., Pothakos K., Tata D.A., McCloskey D.P., Anderson B.J. Chronic administration of corticosterone impairs spatial reference memory before spatial working memory in rats. Neurobiol Learn Mem 2003, 80:11-23.
34. Wright R.L., Lightner E.N., Harman J.S., Meijer O.C., Conrad C.D. Attenuating corticosterone levels on the day of memory assessment prevents chronic stress-induced impairments in spatial memory. Eur J Neurosci 2006, 24(2):595-605.
35. Sgoifo A., Papi F. Effects of social and non-social acute stressors on plasma levels of cate-cholamines and corticosterone in wild rats. Rendiconti Lincei 1995, 6:289-298.
36. Nur Azlina M.F., Nafeeza M.I. Tocotrienol and alpha-tocopherol reduce corticosterone and noradrenalin levels in rats exposed to restraint stress. Pharmazie 2008, 63(12):890-892.
37. Haile M., Limson F., Gingrich K., Li Y.S., Quartermain D., Blanck T., et al. Nimodipine prevents transient cognitive dysfunction after moderate hypoxia in adult mice. J Neurosurg Anesthesiol 2009, 21(2):140-144.
38. Perhonen M., Takala T., Huttunen P., Leppaluoto J. Stress hormones after prolonged physical training in normo- and hypobaric conditions in rats. Int J Sports Med 1995, 16(2):73-77.
39. Jellinck P.H., Dhabhar F.S., Sakai R.R., McEwen B.S. Long-term corticosteroid treatment but not chronic stress affects 11-β-hydroxysteroid dehydrogenase type I activity in rat brain and peripheral tissues. J Steroid Biochem Mol Biol 1997, 60(5-6):319-323.
40. Pelletier G., Luu-The V., Li S., Bujold G., Labrie F. Localization and glucocorticoid regulation of 11beta-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain. Neuroscience 2007, 145(1):110-115.
41. Rogalska J., Kang P., Wotherspoon W., Macleod M.R., Lai M. Effect of hyperthermia and anoxia on glucocorticoid and mineralocorticoid receptor expression in neonatal rat hippocampus. Neurosci Lett 2009, 450(2):196-200.
42. Maurer M.H., Geomor H.K., Brgers H.F., Schelshorn D.W., Kuschinsky W. Adult neural stem cells express glucose transporters GLUT1 and GLUT3 and regulate GLUT3 expression. FEBS Lett 2006, 580(18):4430-4434.
43. Bruckner B.A., Ammini C.V., Otal M.P., Raizada M.K., Stacpoole P.W. Regulation of brain glucose transporters by glucose and oxygen deprivation. Metabolism 1999, 48(4):422-431.
44. Behrooz A., Ismail-Beigi F. Stimulation of glucose transport by hypoxia: signals and mechanisms. News Physiol Sci 1999, 14:105-110.
45. Sapolsky R.M., Packan D.R., Vale W.W. Glucocorticoid toxicity in the hippocampus: in vitro demonstration. Brain Res 1988, 453(1-2):367-371.
46. Hibberd C., Yau J.L., Seckl J.R. Glucocorticoids and the ageing hippocampus. J Anat 2000, 553-562.
47. Roozendaal B., Phillips R.G., Power A.E., Brooke S.M., Sapolsky R.M., McGaugh J.L. Memory retrieval impairment induced by hippocampal CA3 lesions is blocked by adrenocortical suppression. Nat Neurosci 2001, 12:1169-1171.
48. Rupprecht R., Ströhle A., Hermann B., di Michele F., Spalletta G., Pasini A., et al. Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers. Biol Psychiatry 1998, 44(9):912-914.
49. Schurr A. Bench-to-bedside review: a possible resolution of the glucose paradox of cerebral ischemia. Crit Care 2002, 6(4):330-334.
50. Wass C.T., Lanier W.L. Glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clin Proc 1996, 71(8):801-812.
51. Rahman I., Antonicelli F., MacNee W. Molecular mechanism of the regulation of glutathione synthesis by tumor necrosis factor-alpha and dexamethasone in human alveolar epithelial cells. J Biol Chem 1999, 274(8):5088-5096.
52. Joëls M., Karst H., DeRijk R., de Kloet E.R. The coming out of the brain mineralocorticoid receptor. Trends Neurosci 2008, 31(1):1-7.
53. Oitzl M.S., Fluttert M., de Kloet E.R. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur J Neurosci 1994, 6:1072-1079.
54. Krugers H.J., Maslam S., Korf J., Joëls M., Holsboer F. The corticosterone synthesis inhibitor metyrapone prevents hypoxia/ischemia-induced loss of synaptic function in the rat hippocampus. Stroke 2000, 31(5):1162-1172.
55. Lambert J.J., Belelli D., Hill-Venning C., Peters J.A. Neurosteroids and GABAA receptor function. Trends Pharmacol Sci 1995, 16:295-303.
56. 2+channel current in freshly isolated hippocampal CA1 neurons. Eur J Pharmacol 1991, 202:269-272.
57. Roe S.Y., McGowan E.M., Rothwell N.J. Evidence for the involvement of corticotrophin-releasing hormone in the pathogenesis of traumatic brain injury. Eur J Neurosci 1998, 10:553-559.
58. Fantuzzi G., Cantoni L., Sironi M., Ghezzi P. Inhibitors of cytochrome p450 suppress tumor necrosis factor production. Cell Immunol 1993, 150:417-424.
59. Montoliu C., Valles S., Renau-Piqueras J., Guerri C. Ethanol- induced oxygen radical formation and lipid peroxidation in rat brain: effect of chronic alcohol consumption. J Neurochem 1994, 63:1855-1862.
60. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factors protect neurons against excitotoxic/metabolic insults and promote maintenance of calcium homeostatis. Neuron 1994, 12:139-153.
61. Basu M., Sawhney R.C., Kumar S., Pal K., Prasad R., Selvamurthy W. Glucocorticoids as prophylaxis against acute mountain sickness. Clin Endocrinol (Oxf) 2002, 57(6):761-767.
62. Koide T., Wieloch T.W., Siesjö B.K. Chronic dexamethasone pretreatment aggravates ischemic neuronal necrosis. J Cereb Blood Flow Metab 1986, 6(4):395-404.
63. Subedi B.H., Pokharel J., Goodman T.L., Amatya S., Freer L., Banskota N., et al. Complications of steroid use on Mt. Everest. Wilderness Environ Med 2010, 21(4):345-348.
64. Axelrod J., Reisine T.D. Stress hormones: their interaction and regulation. Science 1985, 224:452-460.
65. McEwen B.S., Davis P.G., Parsons B., Pfaff O.W. The brain as a target for steroid hormone action. Annu Rev Neurosci 1979, 2:65-112.